Capnia Inc (CAPN) is Downgraded by Maxim Group to Hold

Capnia Inc (CAPN) was Downgraded by Maxim Group to ” Hold”. Earlier the firm had a rating of “Buy ” on the company shares. Maxim Group advised their investors in a research report released on Nov 23, 2016.

Capnia Inc (CAPN) witnessed a volatile trading activity on Monday , and eventually ended flat at 0.00% or 0 points without letting the bulls or bears take much advantage. The trading began at $0.97 and reached the intraday high at $0.97. The bulls started the profit booking and pushed the shares to intraday low of $0.93. The trading session was marked by a volume range of 7,498 shares exchanging hands. The 52-week high of the shares is $2.59 and the 52-week low is $0.8024. The market cap of the company stands at $15 M and there are 1,57,61,530 shares in public circulation.

In a different news, on Aug 22, 2016, Bhatnagar Anish (director officer ) purchased 10,000 shares at $0.96 per share price. According to the SEC, on Aug 19, 2016, David D O’toole (officer ) purchased 2,000 shares at $1.01 per share price. On May 25, 2016, Steinar J Engelsen (director) purchased 58,200 shares at $1.31 per share price, according to the Form-4 filing with the securities and exchange commission.

Capnia Inc. develops medical diagnostics and therapeutics based on its technology for precision metering of gas flow. The Company’s diagnostic product CoSense aids in the diagnosis of hemolysis in neonates. The Company is applying its research and development efforts to additional diagnostic products based on its Sensalyze Technology Platform a portfolio of methods and devices which enables CoSense and can be applied to detect a variety of analytes in exhaled breath. The Company’s therapeutic technology involves the use of metered nasal carbon dioxide (CO2) for the potential treatment of various diseases. Serenz is the Company’s allergy therapeutic product candidate. It also launched new initiatives for the development of this technology for the treatment of trigeminally mediated pain disorders such as cluster headache and trigeminal neuralgia.

Capnia Inc

Leave a Reply

Capnia Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Capnia Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.